AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-82 Cr | ₹-136 Cr | ₹17 Cr | ₹92 Cr | ₹-81 Cr |
What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-82 Cr |
| Mar2024 | ₹-136 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹-81 Cr |
How is Cash Flow from Financing Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-82 Cr | Negative | |
| Mar2024 | ₹-136 Cr | Negative | |
| Mar2023 | ₹17 Cr | -82.02 | |
| Mar2022 | ₹92 Cr | Positive | |
| Mar2021 | ₹-81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,822.7 Cr | -0.4% | 1.5% | -13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.4% |
1.5% |
-13.5% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses